期刊文献+

5种药物对乳腺癌细胞分化和增殖抑制作用的比较 被引量:1

Effects of Five Different Drugs on Differentiation Induction and Proliferation Inhibition of Breast Cancer Cell Line
原文传递
导出
摘要 [目的]探讨全反式维甲酸(ATRA)、1α,25-二羟维生素D3、盐酸强力霉素、雷洛芬和硫链丝菌肽对乳腺癌细胞MCF-7分化诱导、细胞微环境、细胞增殖影响的差异。[方法]油红O染色检测上述5种药物对MCF-7细胞分化诱导作用;台盼蓝染色检测上述5种药物对MCF-7细胞增殖的抑制作用。[结果 ]5种药物对MCF-7均有很强的分化诱导作用,且呈剂量依赖性。在0.08μmol/L时雷洛芬的分化诱导作用最强,盐酸强力霉素、硫链丝菌肽、1α,25-二羟维生素D3次之。诱导形成的小脂肪滴经油红O染色,显示相似颜色,但高浓度药物诱导形成的大脂肪块染色后,显示颜色的差异,ATRA诱导形成的大脂肪块染色后显示鲜红色,其他4种药物诱导形成的大脂肪块显示较暗的紫红色。脂肪块或脂肪滴主要位于细胞间质,少部分位于胞浆。硫链丝菌肽对MCF-7增殖的抑制作用远强于其他4种药物。[结论]5种药物均可诱导MCF-7细胞分化,改变细胞微环境。在0.08μmol/L时,雷洛芬的分化诱导率最高,盐酸强力霉素、硫链丝菌肽、1α,25-二羟维生素D3次之。它们所形成的脂肪滴成分可能相似,但有所差异。硫链丝菌肽对MCF-7增殖的抑制作用远强于其他4种药物。 [Objective] To investigate the effects of different drugs on differentiation induction and proliferation inhibition of breast cancer MCF-7 cells. [Methods] Human breast cancer MCF-7cells were treated with ATRA,calcitriol,doxycycline,raloxifene or thiostrepton in vitro,respectively. The differentiation induction of MCF-7 cells was detected by Oil Red O staining. The cell proliferation was measured by trypan blue assay. [Results] The differentiation of MCF-7 was induced by all 5 drugs in a dose-dependent manner. Among 5 different drugs,raloxifene was the most effective inducer at 0.08μmol/L,followed by doxycycline,thiostrepton and calcitriol. The induced lipid droplets showed similar color after Oil Red O staining. However,the lipid chunks accumulated by small lipid droplets induced by the above 5 different drugs at high concentrations showed different coloring after Oil Red O staining: the lipid chunks,induced by ATRA appeared to be bright red and the ones induced by other 4 drugs were dark purple. The lipid chunks or droplets were mainly located in the extracellular matrix,with few in cytoplasm. The proliferation inhibition of MCF-7 cells by thiostrepton was much stronger than that by other 4 drugs in a dosedependent manner. [Conclusion] ATRA,calcitriol,doxycycline,raloxifene or thiostrepton can induce the differentiation of breast cancer MCF-7 cells with various degrees. Among 5 drugs,thiostrepton has the strongest effect on the proliferation inhibition of MCF-7 cells.
出处 《肿瘤学杂志》 CAS 2016年第6期452-456,共5页 Journal of Chinese Oncology
关键词 分化 MCF-7 细胞微环境 增殖抑制作用 differentiation MCF-7 microenvironment proliferation inhibition
  • 相关文献

参考文献18

  • 1Xiong R,Patel HK,Gutgesell LM,et al. Selective human estrogen receptor partial agonists (ShERPAs) for tamoxifen- resistant breast cancer[J]. J Med Chem,2016,59(1):219- 237.
  • 2Aseyev O,Ribeiro JM,Cardoso F. Review on the clinical use of eribulin mesylate for the treatment of breast cancer [J]. Expert Opin Pharmacother, 2016,17(4) : 589-600.
  • 3Arisi MF,Starker RA,Addya S,et al. All trans-retinoie acid (ATRA) induces re-differentiation of early trans- formed breast epithelial cells[J]. Int J Oneol,2014,44(6): 1831-1842.
  • 4Jeong Y,Swami S, Krishnan AV,et al. Inhibition of mouse breast tumor initiating cells by calcitriol and dietary vita- min D[J]. Mol Cancer Ther,2015,14(8): 1951-1961.
  • 5Lamb R, Ozsvari B ,Lisanti CL, et al. Antibiotics that tar- get mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an in- fectious disease[J]. Oncotarget,2015,6(7) :4569-4584.
  • 6Kim DE,Kim Y,Cho DH,et al. Raloxifene induces au- tophagy-dependent cell death in breast cancer cells via the activation of AMP-activated protein kinase[J]. Mol Cells, 2015,38(2): 138-144.
  • 7Wang M,Gartel AL. Combination with bortezomib en-hances the antitumor effects of nanoparticle- encapsulated thiostrepton[J]. Cancer Biol Ther, 2012,13(3) : 184-189.
  • 8Smythies J. Intercellular signaling in cancer-the SMT and TOFT hypotheses, exosomes,telocytes and metastases : is the messenger in the message[J]. J Cancer, 2015,6(7):604- 609.
  • 9D'Anselmi F,Masiello MG,Cucina A,et al. Microenvi- ronment promotes tumor cell reprogramming in human breast cancer cell lines[J]. PLoS One, 2013,8(12) : e83770.
  • 10张晟婷,赵维莅.肿瘤微环境与非霍奇金淋巴瘤的发病与耐药[J].中华血液学杂志,2014,35(5):466-469. 被引量:7

二级参考文献63

  • 1Solinas G, Germano G, Mantovani A, et al. Tumor-associated macrophages (TAM) as major players of the cancer- related inflammation [ J ]. J Leukoc Biol, 2009, 86 (5): 1065-1073.
  • 2Yoshida N, Oda M, Kuroda Y, et al. Clinical significance of slL- 2R levels in B-cell lymphomas [J]. PLoS One, 2013, 8 (11): e78730.
  • 3Nesterova ES, Kravchenko SK, Gemdzhian EG, et al. Evalua- tion of tumor vascularization and microenvironment in follicular lymphomal [J]. Ter Arkh, 2013, 85(7):57-64.
  • 4Pangault C, Ame-Thomas P, Ruminy P, et al. Follicular lympho- ma cell niche: identification of a preeminent IL- 4- dependent T (FH)-B cell axis[J]. Leukemia, 2010, 24( 12):2080-2089.
  • 5Kaplan MH, Sehra S, Chang HC, et al. Constitutively active STAT6 predisposes toward a lymphoproliferative disorder [J]. Blood, 2007, 110( 13):4367-4369.
  • 6Carbonnelle-Puscian A, Copie-Bergman C, Baia M, et al. The novel immunosuppressive enzyme IL411 is expressed by neoplastic cells of several B-cell lymphomas and by tumor- associated macrophages [ J ]. Leukemia, 2009, 23 ( 5 ) :952-960.
  • 7Boulland ML, Marquet J, Molinier-Frenkel V, et al. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation [J]. Blood, 2007, 110( 1 ):220-227.
  • 8Hu X, Park-Min KH, Ho HH, et al. IFN-gamma-primed macro- phages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Statl [J]. J lmmunol, 2005, 175(6):3637-3647.
  • 9Cohen PL, Kurtin P J, Donovan KA, et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma [ J ]. Br J Haematol, 1998, 101 (2):302-310.
  • 10Argatoff LH, Connors JM, Klasa R J, et al. Mantle cell lympho- ma: a clinicopathologic study of 80 cases [J]. Blood, 1997, 89 (6) :2067-2078.

共引文献11

同被引文献19

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部